New hope for tough pancreatic cancer? early trial tests combo therapy
Disease control
Not yet recruiting
This is an early safety study for people with advanced pancreatic cancer that has spread and stopped responding to standard chemotherapy. It will test a combination of two drugs, cosibelimab and balixafortide, to find the safest dose and see if the treatment is tolerable. The mai…
Phase: PHASE1 • Sponsor: Arsen Osipov • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC